These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38665551)
21. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466 [No Abstract] [Full Text] [Related]
22. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H Front Immunol; 2023; 14():1213947. PubMed ID: 37965307 [TBL] [Abstract][Full Text] [Related]
23. Novel exosome-related risk signature as prognostic biomarkers in glioblastoma. Ding M; Xu Q; Jin X; Han Z; Jiang H; Sun H; Jin Y; Piao Z; Zhang S Front Immunol; 2023; 14():1071023. PubMed ID: 36865549 [TBL] [Abstract][Full Text] [Related]
24. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
25. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients. Zhu Z; Geng R; Zhang Y; Liu J; Bai J J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489 [TBL] [Abstract][Full Text] [Related]
26. Identification and verification of an exosome-related gene risk model to predict prognosis and evaluate immune infiltration for colorectal cancer. Shao H; Yao L; Tao Y; Huang X Medicine (Baltimore); 2023 Oct; 102(40):e35365. PubMed ID: 37800824 [TBL] [Abstract][Full Text] [Related]
27. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer. Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J PeerJ; 2021; 9():e12276. PubMed ID: 34721975 [TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis. Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY Front Oncol; 2023; 13():1191660. PubMed ID: 37207166 [TBL] [Abstract][Full Text] [Related]
29. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis. Chen W; Kang Y; Sheng W; Huang Q; Cheng J; Pei S; Meng Y Front Immunol; 2024; 15():1331841. PubMed ID: 38370403 [TBL] [Abstract][Full Text] [Related]
30. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction. Sun Y; Yang M; Zhang Q Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642 [TBL] [Abstract][Full Text] [Related]
31. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma. Li R; Zhao W; Liang R; Jin C; Xiong H Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972 [No Abstract] [Full Text] [Related]
33. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response. Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872 [TBL] [Abstract][Full Text] [Related]
34. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Zheng H; Liu H; Li H; Dou W; Wang X Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770 [No Abstract] [Full Text] [Related]
35. An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. Wang H; Wang R; Luo L; Hong J; Chen X; Shen K; Wang Y; Huang R; Wang Z Front Immunol; 2023; 14():1295558. PubMed ID: 38124743 [TBL] [Abstract][Full Text] [Related]
36. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
37. Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer. Zhang LH; Li LQ; Zhan YH; Zhu ZW; Zhang XP Front Mol Biosci; 2021; 8():607090. PubMed ID: 33937319 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy. Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q Front Immunol; 2023; 14():1301452. PubMed ID: 38045683 [TBL] [Abstract][Full Text] [Related]
39. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells. Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150 [TBL] [Abstract][Full Text] [Related]
40. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma. Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]